Publicaciones I.E.N. Endocrinología Clínica XVIII

Díaz-Soto G, Torres Torres B, López JJ, García S, Álvarez Quiñones M, D de Luis. Incidence and dynamic risk stratification in differentiated thyroid cancer in a high-resolution clinic, 2002-2017. Endocrinol Diabetes Nutr (Engl Ed). 2021 2021;68:636-41: FI1,42

D.A. de Luis, D. Primo, O. Izaola, J Lopez Cholesteryl Ester Transfer Protein RS5833 Genetic Variant Affect HDL-cholesterol levels and ratio total cholesterol/HDL-cholesterol in postmenopausal obese female patient. European Review for Medical and Pharmacological Sciences 2021; 25: 7030-7036 FI 3.5

Sicras-Mainar A, Aller R, Crespo J, Calleja JL, Turnes J, Romero Gómez M, Augustín S. Overall clinical and economic impact of non-alcoholic fatty liver disease. Rev Esp Enferm Dig. 2021 Jun;113(6):396-403. doi: 10.17235/reed.2020.7238/2020. PMID: 33222473. FI 2.19

Martín-Fernández M, Tamayo-Velasco Á, Aller R, Gonzalo-Benito H, Martínez-Paz P, Tamayo E. Endothelial Dysfunction and Neutrophil Degranulation as Central Events in Sepsis Physiopathology. Int J Mol Sci. 2021 Jun 10;22(12):6272. doi: 10.3390/ijms22126272. PMID: 34200950. FI5.9

Bayoumi A, Elsayed A, Han S, Petta S, Adams LA, Aller R, Khan A, García-Monzón C, Arias-Loste MT, Miele L, Latchoumanin O, Alenizi S, Gallego-Durán R, Fischer J, Berg T, Craxì A, Metwally M, Qiao L, Liddle C, Yki-Järvinen H, Bugianesi E, Romero-Gomez M, George J, Eslam M. Mistranslation Drives Alterations in Protein Levels and the Effects of a Synonymous Variant at the Fibroblast Growth Factor 21 Locus. Adv Sci (Weinh). 2021 May 1;8(11):2004168. doi: 10.1002/advs.202004168. PMID: 34141520; PMCID: PMC8188187.FI 16.8

Younes R, Caviglia GP, Govaere O, Rosso C, Armandi A, Sanavia T, Pennisi G, Liguori A, Francione P, Gallego-Durán R, Ampuero J, Garcia Blanco MJ, Aller R, Tiniakos D, Burt A, David E, Vecchio FM, Maggioni M, Cabibi D, Pareja MJ, Zaki MYW, Grieco A, Fracanzani AL, Valenti L, Miele L, Fariselli P, Petta S, Romero-Gomez M, Anstee QM, Bugianesi E. Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease. J Hepatol. 2021 Jun 3:S0168-8278(21)00343-3. doi: 10.1016/j.jhep.2021.05.008. Epub ahead of print. PMID: 34090928.FI 25

Ampuero J, Aller R, Gallego-Durán R, Crespo J, Abad J, González-Rodríguez Á, Gómez-Camarero J, Caballería J, Lo Iacono O, Ibañez L, García-Samaniego J, Martín-Mateos R, Francés R, Fernández-Rodríguez C, Diago M, Soriano G, Andrade RJ, Latorre R, Jorquera F, Morillas RM, Escudero D, Estévez P, Hernández-Guerra M, Augustín S, Pareja-Megia MJ, Banales JM, Aspichueta P, Benlloch S, Rosales JM, Salmerón J, Turnes J, Romero-Gómez M; HEPAmet Registry. Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects. Liver Int. 2021 Apr 25. doi: 10.1111/liv.14898. Epub ahead of print. PMID: 33896100.Fi 5.82

Younes R, Govaere O, Petta S, Miele L, Tiniakos D, Burt A, David E, Vecchio FM, Maggioni M, Cabibi D, McLeod D, Pareja MJ, Fracanzani AL, Aller R, Rosso C, Ampuero J, Gallego-Durán R, Armandi A, Caviglia GP, Zaki MYW, Liguori A, Francione P, Pennisi G, Grieco A, Birolo G, Fariselli P, Eslam M, Valenti L, George J, Romero-Gómez M, Anstee QM, Bugianesi E. Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach? Gut. 2021 Feb 4:gutjnl-2020-322564. doi: 10.1136/gutjnl-2020-322564. Epub ahead of print. PMID: 33541866.FI 23

Calzadilla-Bertot L, Vilar-Gomez E, Wong VW, Romero-Gomez M, Aller-de la Fuente R, Wong GL, Castellanos M, Eslam M, Desai AP, Jeffrey GP, George J, Chalasani N, Adams LA. ABIDE: An Accurate Predictive Model of Liver Decompensation in Patients With Nonalcoholic Fatty Liver-Related Cirrhosis. Hepatology. 2021 Jun;73(6):2238-2250. doi: 10.1002/hep.31576. Epub 2021 Apr 19. PMID: 32978796.FI 17.4

Metwally M, Bayoumi A, Khan A, Adams LA, Aller R, García-Monzón C, Arias-Loste MT, Bugianesi E, Miele L, Anna A, Latchoumanin O, Han S, Alenizi S, Sharkawy RE, Elattar A, Gallego-Durán R, Fischer J, Berg T, Liddle C, Romero-Gomez M, George J, Eslam M. Copy number variation and expression of exportin-4 associates with severity of fibrosis in metabolic associated fatty liver disease. EBioMedicine. 2021 Aug 10;70:103521. doi: 10.1016/j.ebiom.2021.103521. Epub ahead of print. PMID: 34388518.FI 8,14

Tamayo-Velasco Á, Peñarrubia-Ponce MJ, Álvarez FJ, Gonzalo-Benito H, de la Fuente I, Martín-Fernández M, Eiros JM, Martínez-Paz P, Miramontes-González JP, Fiz-López A, Arribas-Rodríguez E, Cal-Sabater P, Aller R, Dueñas C, Heredia-Rodríguez M, Tamayo E, Bernardo D, Gómez-Sánchez E. Evaluation of Cytokines as Robust Diagnostic Biomarkers for COVID-19 Detection. J Pers Med. 2021 Jul 20;11(7):681. dFI 4,9

Martín-Fernández M, Aller R, Heredia-Rodríguez M, Gómez-Sánchez E, Martínez-Paz P, Gonzalo-Benito H, Sánchez-de Prada L, Gorgojo Ó, Carnicero-Frutos I, Tamayo E, Tamayo-Velasco Á. Lipid peroxidation as a hallmark of severity in COVID-19 patients. Redox Biol. 2021 Nov 6;48:102181. FI 11.79

Enric Sánchez, Albert Lecube, Diego Bellido, Susana Monereo, María M. Malagón Francisco J. Tinahones and on behalf of the Spanish Society for the Study of Obesity Leading Factors for Weight Gain during COVID-19 Lockdown in a Spanish Population: A Cross-Sectional Study Cross-Sectional Study. Nutrients 2021, 13, 894.

Isabel Cornejo-Pareja , Isabel M Vegas-Aguilar, José Manuel García-Almeida , Diego Bellido-Guerrero , Antonio Talluri , Henry Lukaski , Francisco J. Tinahones. Phase angle and standardized phase angle from bioelectrical impedance measurements as a prognostic factor for mortality at 90 days in patients with COVID-19: A longitudinal cohort study. Clin Nutr (IF: 7.32; Q1). 2021 Feb 17:S0261-5614(21)00091-1.